Mr. Alex Blodgett reports

AMP GERMAN CANNABIS GROUP ANNOUNCES TRADE FINANCING FOR THE IMPORT OF EU-GMP MEDICAL CANNABIS INTO GERMANY

AMP German Cannabis Group Inc. has successfully increased the loan amount it can borrow on its drawdown loan facility announced on Dec. 3, 2018, from 500,000 euros to one million euros to finance trade receivables from the import of medical cannabis from the Netherlands in the coming weeks. The amended drawdown facility will mature on Dec. 31, 2021, and borrowed amounts can be repaid at any time without penalty.

AMP has also closed its non-brokered private placement announced on Jan. 8, 2020, which raised total gross proceeds of $867,500 through the issuance of 3.47 million common shares at a subscription price of 25 cents per share in the first tranche closing announced on March 6, 2020.

Alex Blodgett, chief executive officer of AMP German Cannabis Group, commented: "We appreciate the support of our banking partner for increasing our loan facility. Accordingly, we decided not to accept further subscriptions for our private placement to avoid unnecessary dilution. In addition, due to strong demand for medical cannabis, we will be strengthening our distribution in Germany by adding additional pharmaceutical wholesalers as we begin imports from the Netherlands and Canada."

About AMP German Cannabis Group Inc.

AMP German Cannabis Group is a specialized importer of EU-GMP (European Union good manufacturing practices) medical cannabis into Germany.

We seek Safe Harbor.